The store will not work correctly when cookies are disabled.
(2R,3S)-3-allylmalic acid
ID: ALA376565
PubChem CID: 44423276
Max Phase: Preclinical
Molecular Formula: C7H10O5
Molecular Weight: 174.15
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: (2R,3S)-3-Allylmalic Acid | (2R,3S)-3-allylmalic acid|CHEMBL376565|SCHEMBL7421629
Canonical SMILES: C=CC[C@H](C(=O)O)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C7H10O5/c1-2-3-4(6(9)10)5(8)7(11)12/h2,4-5,8H,1,3H2,(H,9,10)(H,11,12)/t4-,5+/m0/s1
Standard InChI Key: DRCAYRSHVJTTSP-CRCLSJGQSA-N
Molfile:
RDKit 2D
12 11 0 0 1 0 0 0 0 0999 V2000
14.6206 -21.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3351 -21.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0528 -21.8868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3384 -20.6493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6210 -22.7165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9068 -23.1294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3357 -23.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3386 -23.9556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0524 -22.7177 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9060 -21.4752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1917 -21.8879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4771 -21.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
5 7 1 6
2 4 2 0
7 8 1 0
7 9 2 0
1 5 1 0
1 10 1 6
1 2 1 0
10 11 1 0
5 6 1 0
11 12 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 174.15 | Molecular Weight (Monoisotopic): 174.0528 | AlogP: -0.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 94.83 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.61 | CX Basic pKa: ┄ | CX LogP: 0.01 | CX LogD: -5.27 |
Aromatic Rings: ┄ | Heavy Atoms: 12 | QED Weighted: 0.50 | Np Likeness Score: 1.28 |
References
1. Yamamoto T, Miyazaki K, Eguchi T.. (2007) Substrate specificity analysis and inhibitor design of homoisocitrate dehydrogenase., 15 (3): [PMID:17116397] [10.1016/j.bmc.2006.11.008] |